VVTM — VVT Med Income Statement
0.000.00%
Last trade - 00:00- CA$21.42m
- CA$21.18m
Annual income statement for VVT Med, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Revenue | |||||
| Total Revenue | 0.22 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | -0.105 | 0 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | -4.4 | 0.202 | 0.106 | 0.136 | 0.115 |
| Operating Profit | 4.62 | -0.202 | -0.106 | -0.136 | -0.115 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.62 | -0.194 | -0.106 | -0.136 | -0.115 |
| Net Income After Taxes | 4.62 | -0.194 | -0.106 | -0.136 | -0.115 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.62 | -0.194 | -0.106 | -0.136 | -0.115 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.62 | -0.194 | -0.106 | -0.136 | -0.115 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.874 | -0.077 | -0.041 | -0.053 | -0.045 |